Farallon Capital Management’s Pfizer PFE Stock Holding History

Farallon Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,000,000	Closed	-$43M	–	312
2021 Q3	$43M	Buy	+1,000,000	New	+$44.3M	0.2%	78

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Farallon Capital Management's PFE Position: Q3 2014 in Review

Farallon Capital Management sold out of Pfizer (PFE) in Q3 2014, closing a stake of 1,059,270 shares — an estimated $29.8M sold.

Farallon Capital Management first reported a position in PFE in Q2 2013 and held it in 2 quarters. The position peaked at $36.3M in Q2 2013. 1,742 funds tracked by Wall St. Rank hold PFE as of Q3 2014.

Farallon Capital Management reported no remaining Pfizer position as of Q3 2014 after selling out during the quarter.
Farallon Capital Management sold 1,059,270 Pfizer shares in Q3 2014, an estimated $29.8M.
Farallon Capital Management first reported a position in Pfizer in Q2 2013 and held it in 2 quarters.
Farallon Capital Management's Pfizer position peaked at $36.3M in Q2 2013.
1,742 funds tracked by Wall St. Rank held Pfizer as of Q3 2014.

Based on Farallon Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.